Investment28 March 2026 at 07:31 am
Senores Pharmaceuticals Allots 11,70,000 Convertible Equity Warrants
AI Summary
Senores Pharmaceuticals Limited has allotted 11,70,000 Convertible Equity Warrants. The warrants, each carrying a right to subscribe to 1 Equity Share, are priced at ₹812/- per warrant. The total amount for these warrants is ₹ 95,00,40,000/-. The allotment was approved by the Members of the Company on January 31, 2026, and the Board of Directors on March 28, 2026. The warrants will be subject to lock-in restrictions as prescribed under the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018. The allotment was made to Swapnil Jatin Shah, Ashokbhai Vijaysinh Barot, Renosen Pharmaceuticals Private Limited, Sangeeta Mukur Barot, and Viraj Ashokkumar Barot.
Key Highlights
- Senores Pharmaceuticals allotted 11,70,000 Convertible Equity Warrants.
- Each warrant is priced at ₹812/- and carries a right to subscribe to 1 Equity Share.
- The total amount for these warrants is ₹ 95,00,40,000/-.
- The allotment was approved by the Members of the Company on January 31, 2026, and the Board of Directors on March 28, 2026.
- The warrants will be subject to lock-in restrictions as prescribed under the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018.